RNA

Latest SEC Filings & News for RNA

1 most recent filing and news item mentioning RNA. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/RNA/news?limit=20"

Pull RNA filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Atrium Therapeutics Receives FDA Clearance for ATR 1072 IND

Atrium Therapeutics obtained FDA clearance to launch the Phase 1/2 Corventis trial for the precision cardiology candidate ATR 1072. This regulatory milestone validates the company's approach to treating rare genetic cardiomyopathies.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.